Targeted Immunotherapy Is Redefining What High-Risk Means in Adult B-Cell Leukemia
A new review explains how targeted immunotherapies are stripping predictive power from traditional risk markers in adult B-cell acute lymphoblastic ...
A new review explains how targeted immunotherapies are stripping predictive power from traditional risk markers in adult B-cell acute lymphoblastic ...
A new study reports that MDM4 promotes glycolysis and proliferation in TP53-mutant oral squamous cell carcinoma by stabilizing the enzyme ...
A new in vitro study reports that APR-246 enhanced venetoclax's anti-proliferative and pro-apoptotic effects in TP53 R248Q-mutated AML cell lines, ...
Researchers built a seven-gene tumor stemness signature from single-cell and bulk transcriptomic data that predicts survival, immunotherapy response, and oxaliplatin ...
A case report describes how persistent monocytosis documented over more than a year led clinicians to reclassify an 88-year-old man's ...
A single-patient case report documents mixed adenocarcinoma and squamous cell carcinoma arising in an adult sacrococcygeal teratoma during prolonged TNF-alpha ...
A new meta-analysis of 4,070 patients identifies EGFR L858R, poor performance status, and brain metastases as high-certency predictors of poorer ...
A Brazilian study finds that abnormal p53 expression identifies recurrence risk in non-invasive high-grade endometrial cancer, while wild-type tumors show ...
A large computational study links TTN/TP53 co-mutations in gastric cancer to a prognostically favorable population of tumor-associated atypical B cells ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.